NEW YORK (GenomeWeb) – Fluidigm today announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock at a price of $6.75 per share, for aggregate gross proceeds of about $55 million.

In addition, Fluidigm has granted underwriters of the offering a 30-day option to purchase up to 1,222,500 additional shares of common stock at the public offering price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.